Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Bioscience symbols : Aadi save search
Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)
Published: 2024-03-17 (Crawled : 12:20) - prnewswire.com
AADI | $1.795 -1.37% 13K
|
Manufacturing
| Email alert
Add to watchlist
origin bioscience advanced
Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update
Published: 2024-03-13 (Crawled : 14:30) - biospace.com/
AADI | $1.795 -1.37% 13K
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: 0.0%
bioscience update financial results
Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update
Published: 2024-03-06 (Crawled : 17:00) - biospace.com/
AADI | $1.795 -1.37% 13K
|
Manufacturing
|
| O: 0.47%
H: 4.72%
C: 2.83%
report bioscience update results
Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa
Published: 2024-03-01 (Crawled : 22:00) - biospace.com/
AADI | $1.795 -1.37% 13K
|
Manufacturing
|
| O: 1.02%
H: 0.0%
C: 0.0%
fyarro bioscience publication treatment
Aadi Bioscience to Present at the TD Cowen 44th Annual Healthcare Conference
Published: 2024-02-26 (Crawled : 21:00) - prnewswire.com
AADI | $1.795 -1.37% 13K
|
Manufacturing
|
| O: 0.51%
H: 7.53%
C: 4.02%
conference bioscience
Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium
Published: 2024-01-26 (Crawled : 22:00) - prnewswire.com
AADI | $1.795 -1.37% 13K
|
Manufacturing
| Email alert
Add to watchlist
symposium bioscience
Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium
Published: 2024-01-19 (Crawled : 22:00) - prnewswire.com
AADI | $1.795 -1.37% 13K
|
Manufacturing
| Email alert
Add to watchlist
symposium bioscience gastrointestinal
Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating Alterations
Published: 2023-12-14 (Crawled : 21:00) - prnewswire.com
AADI | $1.795 -1.37% 13K
|
Manufacturing
|
| O: -56.42%
H: 15.81%
C: 0.0%
tumors bioscience trial results
Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate Update
Published: 2023-11-08 (Crawled : 14:00) - biospace.com/
AADI | $1.795 -1.37% 13K
|
Manufacturing
|
| O: -1.24%
H: 0.0%
C: -2.31%
bioscience update financial results
Aadi Bioscience to Participate in Jefferies London Healthcare Conference
Published: 2023-11-06 (Crawled : 21:00) - prnewswire.com
AADI | $1.795 -1.37% 13K
|
Manufacturing
|
| O: -0.82%
H: 1.04%
C: 0.21%
conference bioscience
Aadi Bioscience to Report Third Quarter 2023 Results and Operational Update
Published: 2023-11-01 (Crawled : 20:00) - prnewswire.com
AADI | $1.795 -1.37% 13K
|
Manufacturing
|
| O: 0.69%
H: 6.9%
C: 5.75%
report bioscience update results
Aadi Bioscience Announces Poster Presentations on Nab-Sirolimus at the International Gynecologic Cancer Society (IGCS) 2023 Annual Global Meeting
Published: 2023-10-19 (Crawled : 20:00) - prnewswire.com
AADI | $1.795 -1.37% 13K
|
Manufacturing
|
| O: 1.52%
H: 3.98%
C: 1.74%
bioscience cancer international global meeting
Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Published: 2023-10-12 (Crawled : 20:00) - prnewswire.com
AADI | $1.795 -1.37% 13K
|
Manufacturing
|
| O: -2.78%
H: 1.43%
C: 0.71%
conference bioscience cancer international therapeutics molecular
Aadi Bioscience Announces Poster Presentations at the North American Neuroendocrine Tumor Society (NANETS) 2023 Multidisciplinary NET Medical Symposium
Published: 2023-10-05 (Crawled : 20:00) - prnewswire.com
AADI | $1.795 -1.37% 13K
|
Manufacturing
|
| O: -1.37%
H: 5.34%
C: 3.94%
symposium bioscience tumor medical
Aadi Bioscience Grants New CEO Dave Lennon, Ph.D. Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)
Published: 2023-10-03 (Crawled : 20:00) - prnewswire.com
AADI | $1.795 -1.37% 13K
|
Manufacturing
|
| O: 0.25%
H: 4.47%
C: 4.22%
award ceo nasdaq bioscience grants
Aadi Bioscience Appoints Dave Lennon, Ph.D. as President and Chief Executive Officer
Published: 2023-10-02 (Crawled : 14:00) - biospace.com/
AADI | $1.795 -1.37% 13K
|
Manufacturing
|
| O: 3.1%
H: 0.2%
C: -13.83%
NVS | News | $92.79 -0.31% 210K
|
Health Technology
|
| O: 0.19%
H: 0.03%
C: -0.5%
bioscience
Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Published: 2023-09-20 (Crawled : 21:00) - prnewswire.com
AADI | $1.795 -1.37% 13K
|
Manufacturing
|
| O: -0.57%
H: 0.19%
C: -0.38%
conference bioscience cancer international therapeutics molecular
Aadi Bioscience to Participate at Upcoming Investor Conferences - September 5, 2023
Published: 2023-09-05 (Crawled : 14:30) - biospace.com/
AADI | $1.795 -1.37% 13K
|
Manufacturing
|
| O: 1.02%
H: 0.34%
C: -7.26%
MS | News 0 d | $90.84 0.84% 900K
|
Finance
|
| O: 0.01%
H: 0.0%
C: 0.0%
bioscience
Aadi Bioscience Announces Financial Results for the Second Quarter 2023 and Provides Corporate Update
Published: 2023-08-09 (Crawled : 13:20) - biospace.com/
AADI | $1.795 -1.37% 13K
|
Manufacturing
|
| O: -4.97%
H: 0.0%
C: 0.0%
bioscience update financial results
Aadi Bioscience to Report Second Quarter 2023 Results and Operational Update
Published: 2023-08-02 (Crawled : 14:00) - biospace.com/
AADI | $1.795 -1.37% 13K
|
Manufacturing
|
| O: -0.57%
H: 1.92%
C: 0.77%
report bioscience update results
Gainers vs Losers
| 81% | 19% |
Top 10 Gainers
AGBA | $0.8978 124.45% 60M
|
Finance
BPTH | $6.18 90.74% 39M
|
Health Technology
INVO | $1.44 89.47% 3M
|
Health Technology
TIRX | $0.8258 70.34% 50M
|
XPON | $2.66 37.82% 5.2M
|
SINT | $0.0504 35.12% 300M
|
Health Technology
ALRN | $5.605 31.88% 210K
|
Health Technology
HOLO | $2.92 30.36% 22M
|
SMSI 4 | $2.53 29.74% 510K
|
Technology Services
VTNR S | $1.25 27.66% 3.2M
|
Industrial Services
Your saved searches
Save your searches and get alerts when important news are released.